Ocean Biomedical Cash Flow Statement 2021-2024 | OCEA

Fifteen years of historical annual cash flow statements for Ocean Biomedical (OCEA).

Annual Data | Millions of US $ except per share data

Metric Name
Net Income/Loss
Total Depreciation And Amortization - Cash Flow
Other Non-Cash Items
Total Non-Cash Items
Change In Accounts Receivable
Change In Inventories
Change In Accounts Payable
Change In Assets/Liabilities
Total Change In Assets/Liabilities
Cash Flow From Operating Activities
Net Change In Property, Plant, And Equipment
Net Change In Intangible Assets
Net Acquisitions/Divestitures
Net Change In Short-term Investments
Net Change In Long-Term Investments
Net Change In Investments - Total
Investing Activities - Other
Cash Flow From Investing Activities
Net Long-Term Debt
Net Current Debt
Debt Issuance/Retirement Net - Total
Net Common Equity Issued/Repurchased
Net Total Equity Issued/Repurchased
Total Common And Preferred Stock Dividends Paid
Financial Activities - Other
Cash Flow From Financial Activities
Net Cash Flow
Stock-Based Compensation
Common Stock Dividends Paid
20222021
$-0.96$-0.56
$0$0
$-1.52$0.00
$-1.52$0.00
$0$0
$0$0
$0.29$0.03
$0.38$-0.47
$1.74$-0.23
$-0.75$-0.79
$0$0
$0$0
$0$0
$0$0
$-2.10$-107.10
$-2.10$-107.10
$0$0
$-2.10$-107.10
$0$0
$2.10$0
$2.10$0
$0$109
$0$109
$0$0
$0$-0.15
$2.10$109
$-0.75$1.08
$0$0
$0$0